Workflow
Oncolytics Biotech (ONCY) - 2024 Q2 - Quarterly Report

Condensed Interim Consolidated Financial Statements (unaudited) Oncolytics Biotech Inc. For the three and six months ended June 30, 2024 ® ONCOLYTICS BIOTECH INC. CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (unaudited) (in thousands of Canadian dollars, except share amounts) | | | June 30, | | December 31, | | --- | --- | --- | --- | --- | | As at | | 2024 | | 2023 | | Assets | | | | | | Current assets | | | | | | Cash and cash equivalents (note 4) | 24,850| 24,850 | | 34,912 | | Other rec ...